Ignite Creation Date:
2025-12-24 @ 4:37 PM
Ignite Modification Date:
2025-12-27 @ 12:24 AM
Study NCT ID:
NCT00911066
Status:
COMPLETED
Last Update Posted:
2013-12-05
First Post:
2009-05-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
MLN4924 for the Treatment of Acute Myelogenous Leukemia, Myelodysplastic Syndrome, and Acute Lymphoblastic Leukemia
Sponsor:
Millennium Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-06
Start Date Type:
None
Primary Completion Date:
2013-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-10
Completion Date Type:
ACTUAL
First Submit Date:
2009-05-28
First Submit QC Date:
None
Study First Post Date:
2009-06-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-12-03
Last Update Post Date:
2013-12-05
Last Update Post Date Type:
ESTIMATED